Abstract
Stimulation of adenosine A1receptors is known to reduce infarct size in the rabbit heart. The aim of the present study was to verify whether a protective activity similar to that of the selective A1receptor agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), could also be obtained by inducing comparable hemodynamic effects with drugs having different mechanisms of action. The effects of theβ-adrenoceptor blocker atenolol, the calcium channel blocker felodipine, the A2A-selective adenosine receptor agonist 2-hexynyl-5′-N-ethyl-carboxamidoadenosine (2HE-NECA), and the non-selective adenosine receptor agonist 5′-N-ethyl-carboxamidoadenosine (NECA) were tested.Groups of 12–15 anesthetized open-chest rabbits received a 5-min infusion of CCPA (50gmgkg−1min−1), atenolol (1mgkg−1min−1), felodipine (50gmgkg−1min−1), 2HE-NECA (1gmgkg−1min−1), and NECA (1gmgkg−1min−1). Myocardial infarction was induced by a 30-min occlusion of a branch of the left coronary artery, followed by 3-h reperfusion. Infarct size was measured by tetrazolium staining.In controls, infarct size was about 40% of the zone at risk. Pretreatment with CCPA induced a marked decrease in heart rate (−40%) and blood pressure (−48%), and showed antiischemic activity (28% of the zone at risk). The other drugs tested produced similar effects on either heart rate (atenolol, −25%), or blood pressure (felodipine, 2HE-NECA and NECA, about −45%), but did not affect infarct size.In this model, the reduction in infarct size by CCPA is most likely mediated by A1receptors,since comparable hemodynamic effects, induced by other means, are not effective. A2Areceptor stimulation does not appear to exert a protective effect.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.